Stocktoria

Black Diamond Therapeutics, Inc. BDTX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-01-30

Black Diamond Therapeutics, Inc. statistics & valuation

Market cap$98.0M
P / E4.4×
P / S1.4×
P / B0.9×
Net margin32.0%
Return on equity19.9%
Return on capital9.8%
Graham number +96.9%$4.14

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($4.14); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
32.00% 20182019202020212022202320242025
Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
17.90% 20182019202020212022202320242025
Return on equity (%)
-21.90% -64.10% -78.80% -70.60% -83.70% 19.90% 20182019202020212022202320242025
Shares outstanding
2.2M 2.2M 36.1M 36.2M 36.4M 51.6M 56.6M 57.6M 20182019202020212022202320242025
Net debt ($)
20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-17.20% -22.30% -20.40% -50.70% -58.30% -52.00% -56.80% 15.60% 20182019202020212022202320242025
Free cash flow margin (%)
20182019202020212022202320242025
Debt / equity (×)
20182019202020212022202320242025
EPS ($)
-$2.05 -$3.47 -$2.52 -$1.88 -$1.27 $0.39 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin17.9%———————
Net margin32.0%———————
Return on assets15.6%-56.8%-52.0%-58.3%-50.7%-20.4%-22.3%-17.2%
Return on equity19.9%-83.7%-70.6%-78.8%-64.1%-21.9%74.8%57.5%
Current ratio8.424.926.828.379.1222.4832.0220.07

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.